Skip to content
Bramante Biologics logo

Bramante Biologics

Bramante Biologics is a YC Spring 2025 (P25) company. Based in Cambridge, MA, USA. Team of 2.

  • Biotech
  • Manufacturing
  • AI

About Bramante Biologics

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Bramante Biologics sells cell culture media and buffers, such as DMEM, RPMI, and DPBS, to research labs at uniform list pricing with no negotiation required. It also produces custom media and buffers to a lab's own formulation and fill size, quoted within 24 hours. The company replaces the standard supplier model, where pricing is opaque and turnaround is slow, with same-day shipping on stocked items and a public catalog accessible via an AI agent interface.

Business model

Flat list pricing per product unit, with custom orders quoted individually.

Go-to-market

Research labs buy directly through a self-serve online catalog, with AI-assisted ordering available via an MCP interface for product comparison and purchase preparation.

From the Y Combinator listing

How Bramante Biologics describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

American drug manufacturing

Manufacturing pharmaceutical drugs faster and in the USA

Facts

Industry
Healthcare / Healthcare
Location
Cambridge, MA, USA
Team size
2
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works